M.D. Anderson Cancer Center
The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.
Primary Objectives: • To determine the feasibility of implementing a chatbot-facilitated remote informed consent (IC) process. Secondary Objectives * To identify determinants of patient acceptance and usage of the chatbot. * To determine the accuracy and completeness of information delivered via the chatbot. * To determine the quality of the chatbot-facilitated remote IC process. * To determine the feasibility of using the chatbot for patient eligibility verification.
Inclusion Criteria: * Ability to understand and willingness to provide informed consent. * Age ≥18 years. * Patients whose preferred language is English. * Patients who are being considered for enrollment in selected clinical research studies. Phase I will be initiated using the Clearinghouse protocol PA11-0852, a non-interventional biomarker study. Exclusion Criteria: N/A
A patient-facing chatbot designed to obtain informed consent
Arctuva estimate
Verify or correct the compensation shown for this listing.